Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ryan D Souza

Pain Medicine Rochester, MN Medical Doctor

NPI 1881042174 CMS profile 2364753

200 1St St Sw, Rochester, MN 55905

Open in the dashboard

General payments

$20,588

119 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$12,250 paid to institutions, not to them · program years 2022–2023

Through program year 2025, Ryan D Souza of Rochester, MN is reported in the CMS Open Payments database as having received $20,588 across 119 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $12,250 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,284 24
2024 General $2,018 18
2023 General $1,342 16
2022 General $2,473 23
2021 General $1,644 24
2020 General $558 6
2019 General $270 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan D Souza
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Ryan D Souza were reported at $12,284. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Ryan D Souza Pain Medicine median Middle half National median
2019 $270 $506 $144–$1,566 $163
2020 $558 $315 $96–$934 $114
2021 $1,644 $452 $134–$1,237 $132
2022 $2,473 $475 $124–$1,407 $149
2023 $1,342 $480 $136–$1,384 $160
2024 $2,018 $521 $164–$1,511 $164
2025 $12,284 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vertex Pharmaceuticals Incorporated $10,919 10 payments
  2. Nevro Corp. $2,544 26 payments
  3. Medtronic, Inc. $1,816 17 payments
  4. Boston Scientific Corporation $1,711 13 payments
  5. SPR Therapeutics, Inc $1,017 8 payments
  6. Nalu Medical, Inc. $477 6 payments
  7. Globus Medical, Inc. $397 5 payments
  8. Abbott Laboratories $374 4 payments
  9. Medtronic USA, Inc. $348 4 payments
  10. Stratus Medical, LLC $158 1 payment
  11. Other $826 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,825 4 payments
  2. Food and Beverage $8,347 104 payments
  3. Travel and Lodging $2,074 9 payments
  4. Education $218 1 payment
  5. Consulting Fee $125 1 payment
Products named General payments · program years 2019–2025
  1. JOURNAVX $10,919 10 payments
  2. Superion Indirect Decompression System $1,590 12 payments
  3. Omnia $1,219 12 payments
  4. Senza Spinal Cord Stimulator $1,012 11 payments
  5. INTELLIS ADAPTIVESTIM $971 9 payments
  6. SPRINT PNS System $960 7 payments
  7. Nalu Neurostimulation System $477 6 payments
  8. Senza Spinal Cord Stimulator $397 5 payments
  9. INTELLIS $309 3 payments
  10. INCEPTIV $236 2 payments
  11. Other $2,495 48 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$36,732

Of which drugs: $84

Medicare patients

232

Average age 73

Services billed

551

133 women, 99 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Depression 34%
Chronic kidney disease 32%
Diabetes 28%
Ischemic heart disease 28%
Osteoporosis 26%
Heart failure 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 23 96 $72

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record